June 16, 2020
The Ohio State University College of Pharmacy Division of Medicinal Chemistry and Pharmacognosy and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) recently partnered to build a shared resource focused on phenotypic and target-based screening of libraries of small molecules via high-content and high-throughput approaches. The screening of small molecules against diverse biological targets will generate large data sets that will require storage, curation and analysis.
To facilitate the ability to store the large amount of chemical and biological data, the college has adopted the CDD Vault cloud-based cheminformatics platform for data management. They will additionally use CDD Vault’s integrated electronic lab notebook (ELN) to facilitate the organization and sharing of research results within specific research groups.
“We are excited about enhancing our ability to screen small molecules and using CDD Vault as a state-of-the-art technology to store and analyze data from these projects. CDD Vault will improve collaboration between faculty and staff in the College of Pharmacy, the OSUCCC – James and other academic units on campus. Ultimately it will enhance our ability to discover drugs at Ohio State,” said Blake Peterson, PhD, chair of the college’s Division of Medicinal Chemistry and Pharmacognosy. "For academic researchers involved in drug discovery, CDD Vault provides a powerful and flexible platform for management of data that has been extensively validated both at universities and in biotechnology and pharmaceutical companies.”